Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Schoenberg

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
The Journal of Urology|October 24, 2024
Primary Chemoablation of Recurrent Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer With UGN-102: A Single-Arm, Open-Label, Phase 3 Trial (ENVISION)Sandip M Prasad, Dimitar Shishkov, Nikola Vladimirov Mihaylov, et al.
Urology|December 27, 2022
Natural History of Multiple Recurrences in Intermediate-Risk Non-Muscle Invasive Bladder Cancer: Lessons From a Prospective CohortVidit Sharma, Karim Chamie, Mark Schoenberg, et al.
Cancer|October 13, 2010
Expression status and prognostic significance of mammalian target of rapamycin pathway members in urothelial carcinoma of urinary bladder after cystectomyLuciana Schultz, Roula Albadine, Jessica Hicks, et al.
BJU International|December 17, 2008
Assessing the minimum number of lymph nodes needed at radical cystectomy in patients with bladder cancerUmberto Capitanio, Nazareno Suardi, Shahrokh F Shariat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2006
Nomograms provide improved accuracy for predicting survival after radical cystectomyShahrokh F Shariat, Pierre I Karakiewicz, Ganesh S Palapattu, et al.
Clinical Genitourinary Cancer|December 13, 2021
Safety and Efficacy of Reproductive Organ-Sparing Radical Cystectomy in Women With Variant Histology and Advanced StageSunil H Patel, Shirley Wang, Meredith R Metcalf, et al.
Cancer Research|October 15, 2013
TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urineIsaac Kinde, Enrico Munari, Sheila F Faraj, et al.
The Journal of Urology|November 19, 2024
Long-Term Outcomes of Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma With UGN-101, a Mitomycin Reverse Thermal GelPhillip M Pierorazio, Nir Kleinmann, Ahmad Shabsigh, et al.
Clinical Genitourinary Cancer|July 31, 2025
Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer With UGN-102: Outcomes From the 5-Year Long-Term Extension Study of the Single-Arm, Phase 2b Optima II StudyNeal D Shore, K Kent Chevli, Daniel Saltzstein, et al.
European Urology|July 13, 2006
Precystectomy nomogram for prediction of advanced bladder cancer stagePierre I Karakiewicz, Shahrokh F Shariat, Ganesh S Palapattu, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
The Journal of Urology|October 24, 2024
Primary Chemoablation of Recurrent Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer With UGN-102: A Single-Arm, Open-Label, Phase 3 Trial (ENVISION)Sandip M Prasad, Dimitar Shishkov, Nikola Vladimirov Mihaylov, et al.
Urology|December 27, 2022
Natural History of Multiple Recurrences in Intermediate-Risk Non-Muscle Invasive Bladder Cancer: Lessons From a Prospective CohortVidit Sharma, Karim Chamie, Mark Schoenberg, et al.
Cancer|October 13, 2010
Expression status and prognostic significance of mammalian target of rapamycin pathway members in urothelial carcinoma of urinary bladder after cystectomyLuciana Schultz, Roula Albadine, Jessica Hicks, et al.
BJU International|December 17, 2008
Assessing the minimum number of lymph nodes needed at radical cystectomy in patients with bladder cancerUmberto Capitanio, Nazareno Suardi, Shahrokh F Shariat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2006
Nomograms provide improved accuracy for predicting survival after radical cystectomyShahrokh F Shariat, Pierre I Karakiewicz, Ganesh S Palapattu, et al.
Clinical Genitourinary Cancer|December 13, 2021
Safety and Efficacy of Reproductive Organ-Sparing Radical Cystectomy in Women With Variant Histology and Advanced StageSunil H Patel, Shirley Wang, Meredith R Metcalf, et al.
Cancer Research|October 15, 2013
TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urineIsaac Kinde, Enrico Munari, Sheila F Faraj, et al.
The Journal of Urology|November 19, 2024
Long-Term Outcomes of Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma With UGN-101, a Mitomycin Reverse Thermal GelPhillip M Pierorazio, Nir Kleinmann, Ahmad Shabsigh, et al.
Clinical Genitourinary Cancer|July 31, 2025
Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer With UGN-102: Outcomes From the 5-Year Long-Term Extension Study of the Single-Arm, Phase 2b Optima II StudyNeal D Shore, K Kent Chevli, Daniel Saltzstein, et al.
European Urology|July 13, 2006
Precystectomy nomogram for prediction of advanced bladder cancer stagePierre I Karakiewicz, Shahrokh F Shariat, Ganesh S Palapattu, et al.
Pageof 7